RT @BrainBoxNic: Interferons-beta versus glatiramer acetate for relapsing-remitting multiple sclerosis. - PubMed - NCBI https://t.co/VkF5nf…
Interferons-beta versus glatiramer acetate for relapsing-remitting multiple sclerosis. - PubMed - NCBI https://t.co/VkF5nf4QIi
Interferons-beta versus glatiramer acetate for relapsing-remitting #multiplesclerosis https://t.co/OUtDdi1pag
A comparison of the effectiveness and safety of the two most common therapies for people with... https://t.co/ksA69atWUv via @rincondesisifo
RT @rincondesisifo: (Cochrane) Seguridad y eficacia comparadas de IFN vs glatirámero en esclerosis múltiple https://t.co/ciIvchA2Md
(Cochrane) Seguridad y eficacia comparadas de IFN vs glatirámero en esclerosis múltiple https://t.co/ciIvchA2Md
A comparison of the effectiveness and safety of the two most common therapies for people… https://t.co/LK5DWY7Prh
Interferons-beta versus glatiramer acetate for relapsing-remitting multiple sclerosis. https://t.co/ehtRGHTsmQ